Microbot Medical, Inc. Common Stock MBOT
Analyst Ratings
- Consensus
- Buy — 4 Buy · 0 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $6.38 (+342.7% upside)
Key Stats
- Today's Range
- $1.44 – $1.48
- 50-Day Range
- $1.44 – $2.04
- 52-Week Range
- $1.44 – $4.67
- Volume
- 407K shs
- Average Volume
- 698K shs
- Market Cap
- $96.72 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 3.93%
- Days to Cover
- 5.10
About Microbot Medical, Inc. Common Stock
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
Related Stocks
Compare head-to-head: MBOT vs SYK·MBOT vs BSX·MBOT vs RMD·MBOT vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
